SCHEMBL22708765

SCHEMBL22708765

c1ccc(-c2ccc3oc4c5[nH]c6ccccc6c5c5ccccc5c4c3c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK5 Q00535 4/20 0.49
▸ CDK5R1 Q15078 3/20 0.49
▸ DYRK1A Q13627 3/20 0.49
▸ MAP3K11 Q16584 2/20 0.44
▸ MAP3K9 P80192 1/20 0.44
▸ MEN1 O00255 4/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ MAPT P10636 3/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ PLA2G2A P14555 3/20 0.41
▸ PLA2G4A P47712 3/20 0.41
▸ GSK3A P49840 1/20 0.40
▸ GSK3B P49841 1/20 0.40
▸ PIM1 P11309 1/20 0.39
▸ CSNK2A2 P19784 1/20 0.39
▸ CSNK2B P67870 1/20 0.39
▸ PIM3 Q86V86 1/20 0.39
▸ PIM2 Q9P1W9 1/20 0.39
▸ GABRP O00591 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22708549 0.89 CDK5 (0.49) CDK5CDK5R1DYRK1AMAP3K11MAP3K9
SCHEMBL18132863 0.89 MAP3K11 (0.44) CDK5CDK5R1DYRK1AMAP3K11MAP3K9
SCHEMBL17451766 0.86 CDK5 (0.46) CDK5CDK5R1DYRK1AMAP3K11MAP3K9
SCHEMBL22708929 0.86 MAP3K11 (0.44) CDK5CDK5R1DYRK1AMAP3K11MAP3K9
SCHEMBL16482458 0.84 KDM4E (0.46) CDK5CDK5R1DYRK1AMAP3K11MAP3K9
SCHEMBL22708888 0.83 CDK5 (0.35) CDK5CDK5R1DYRK1AMAP3K11MAP3K9
SCHEMBL30883881 0.82 MAP3K11 (0.59) CDK5CDK5R1DYRK1AMAP3K11MAP3K9
SCHEMBL29506369 0.82 MAP3K11 (0.59) CDK5CDK5R1DYRK1AMAP3K11MAP3K9
SCHEMBL17228831 0.82 MAP3K11 (0.59) CDK5CDK5R1DYRK1AMAP3K11MAP3K9
SCHEMBL19544035 0.82 CDK4 (0.47) CDK5CDK5R1DYRK1AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588110-B2 Heterocyclic compound and organic light emitting device comprising the same LT MATERIALS CO., LTD. (KR) 2023-02-21 — — US disclosed
US-20200373499-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LT MATERIALS CO., LTD. (KR) 2020-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11588110-B2 Heterocyclic compound and organic light emitting device comprising the same CRY1, CYP1A1, CYP1B1 CDK5 1153/4885CDK5R1 1474/4885DYRK1A 4621/4885
US-20200373499-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, CYP1B1 CDK5 1153/4885CDK5R1 1474/4885DYRK1A 4621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback